The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 The gastrointestinal bleeding treatment devices market has witnessed robust growth, surging from $0.84 billion in 2023 to $0.9 billion in 2024, showcasing a commendable Compound Annual Growth Rate (CAGR) of 6.9%. This growth is attributed to various factors such as the aging population, lifestyle factors, healthcare infrastructure, and advancements in endoscopy. Looking ahead, the market is set for strong expansion, reaching $1.2 billion by 2028 at a CAGR of 7.6%.

Rise in Incidences of Upper Gastrointestinal Bleeding

• Increasing incidences of upper gastrointestinal bleeding contribute significantly to market growth.
• Occurring in the esophagus, stomach, or upper small intestine, it can result from peptic ulcers, cancer, and other causes.
• UK reports an incidence range of 84-172 per 100,000 of the population per year.

Key Players and Market Segmentation

• Major companies shaping the market include Boston Scientific Corporation, Olympus Corporation, and Medtronic.
• Market segmentation involves products (Endoscopic Thermal Devices), GI Tract Division (Upper GI Tract, Lower GI Tract), and end-users (Hospitals, Ambulatory Surgical Centers).

Investment in Artificial Intelligence for Gastroenterology

• Companies are investing in artificial intelligence (AI) to enhance efficiency and reduce R&D costs.
• The U.S. FDA granted authorization for GI Genius, an AI-powered device aiding in the immediate detection of lesions during colonoscopy procedures.

Olympus and Hitachi Collaboration for Endoscopic Ultrasound Systems

• Olympus Corporation and Hitachi Ltd collaborated to develop Endoscopic Ultrasound Systems (EUS) in January 2021.
• EUS is used to treat digestive diseases and assess cancer stages in various organs, contributing to minimally invasive care.

View More On The Gastrointestinal Bleeding Treatment Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Market Trends Shaping the Future

• Notable trends in the forecast period include the adoption of non-invasive diagnostic technologies, precision medicine, remote monitoring and telehealth, and the integration of artificial intelligence and machine learning.
• These trends signify the industry’s response to evolving healthcare needs and technological advancements.

Regional Dynamics: North America Leading, Asia-Pacific Emerging

• North America held the largest share in the gastrointestinal bleeding treatment devices market in 2023.
• Asia-Pacific is expected to be the fastest-growing region in the forecast period, reflecting a rising demand for advanced healthcare solutions.

Conclusion
The gastrointestinal bleeding treatment devices market stands at the forefront of healthcare innovation, driven by a surge in upper gastrointestinal bleeding incidences and strategic collaborations. With a focus on artificial intelligence, precision medicine, and cutting-edge technologies, the industry is poised for substantial growth. As we navigate the path towards 2028, the market’s response to patient-centric care, regulatory changes, and the increasing prevalence of gastrointestinal disorders paints a promising picture of an industry at the forefront of transformative healthcare solutions.

Request A Sample Of The Global Gastrointestinal Bleeding Treatment Devices Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=5307&type=smp